TokenPost topic

Petosemtamab

1 TokenPost story is tagged Petosemtamab. The newest appear first.

Latest Petosemtamab stories

• Genmab Says Petosemtamab-Keytruda Combo Cut Mortality Risk 50%

  The Phase 3 data involved certain patients with head and neck cancer. Petosemtamab is a bispecific antibody therapy.

  Oct 28, 2026, 3:23 PM EDT · Business